Insider · CIK 0001309614
Andrew Alasdair Smith
Files at MDCX (Medicus Pharma Ltd.). First filing -, latest -.
In brief
Andrew Alasdair Smith files SEC Form 4 as COO at MDCX (Medicus Pharma Ltd.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew Alasdair Smith has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | MDCX Medicus Pharma Ltd. | AGrant or award Common Shares, no par value | +735,294 | $0.17 | $125k | 735,458 | 35 d ago |
| Sep 4, 2026 | MDCX Medicus Pharma Ltd. | AGrant or award Stock Option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | 35 d ago |
| Jun 3, 2026 | MDCX Medicus Pharma Ltd. | AGrant or award Stock Option (right to buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Jun 4, 2026 |
| Mar 30, 2026 | MDCX Medicus Pharma Ltd. | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Apr 1, 2026 |
| Dec 16, 2025 | MDCX Medicus Pharma Ltd. | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Dec 18, 2025 |
Questions about Andrew Alasdair Smith
Answered from the filings on this page, as of the latest one.
Is Andrew Alasdair Smith buying or selling?
Andrew Alasdair Smith has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew Alasdair Smith's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew Alasdair Smith has 0.
Where does Andrew Alasdair Smith file Form 4?
Andrew Alasdair Smith has filed Form 4 at MDCX (Medicus Pharma Ltd.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.